Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1801PDF: 839HTML: 183 -
Severe Acute Hepatitis B Treated with Entecavir
1610PDF: 837HTML: 2522Figure: 179Title page: 179disclosure: 106 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1399PDF: 778HTML: 533 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1635PDF: 818HTML: 1242Figure 1: 183Figure 2: 196Figure 3: 194 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3485PDF: 1320HTML: 1939Fig.1: 223Fig. 2: 221 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2961PDF: 1364HTML: 164 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
760PDF: 607HTML: 120 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1441PDF: 904HTML: 1881 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2336PDF: 1347HTML: 17105Bassan Fig.1: 154Bassan Fig.2: 168Bassan Fig.4: 145Fig.3: 214 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2240PDF: 1220HTML: 3884 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1156PDF: 514HTML: 251 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
131PDF: 133HTML: 8 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1491PDF: 981HTML: 429 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
719PDF: 266Html: 36 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4257PDF: 1504HTML: 8524 -
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3186PDF: 1159HTML: 1532Untitled: 184Untitled: 177Untitled: 177 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3199PDF: 1418HTML: 14000jdoe, Dening.MarijuanaFi7.doc: 207jdoe, Dening.MarijuanaFi6.doc: 192jdoe, Dening.MarijuanaFi5.doc: 185jdoe, Dening.MarijuanaFi4.doc: 201jdoe, Dening.MarijuanaFi3.doc: 208jdoe, Dening.MarijuanaFi2.doc: 256jdoe, Dening.MarijuanaFig1.doc: 224







